Showing results (741-750 of 784) with videos related to
Sort By:
Pageof 79
Nature Reviews. Rheumatology|September 23, 2017
Synovial tissue research: a state-of-the-art reviewCarl Orr, Elsa Vieira-Sousa, David L Boyle, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate CancerPaula J Hurley, Debasish Sundi, Brian Shinder, et al.Nature Reviews. Rheumatology|December 20, 2017
Corrigendum: Synovial tissue research: a state-of-the-art reviewCarl Orr, Elsa Vieira-Sousa, David L Boyle, et al.Trials|July 17, 2019
Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocolMariam Al-Laith, Marianna Jasenecova, Sonya Abraham, et al.The New England Journal of Medicine|July 25, 2008
Raltegravir with optimized background therapy for resistant HIV-1 infectionRoy T Steigbigel, David A Cooper, Princy N Kumar, et al.The New England Journal of Medicine|July 25, 2008
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infectionDavid A Cooper, Roy T Steigbigel, Jose M Gatell, et al.Research Involvement and Engagement|January 23, 2024
Advancing patient-centered research practices in a pragmatic patient-level randomized clinical trial: A thematic analysis of stakeholder engagement in Emergency Medicine Palliative Care Access (EMPallA)Nicole Zhao, Allison M Cuthel, Owen Storms, et al.Nature Genetics|September 2, 2008
Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12Jielin Sun, Siqun Lilly Zheng, Fredrik Wiklund, et al.Annals of the Rheumatic Diseases|March 4, 2025
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 updatePeter Nash, Andreas Kerschbaumer, Victoria Konzett, et al.Annals of the Rheumatic Diseases|May 1, 2019
Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39Athina Spiliopoulou, Marco Colombo, Darren Plant, et al.Pageof 79